Advertisement
Research Article| Volume 21, ISSUE 2, P126-135, February 2011

Download started.

Ok

Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome

  • P. Casas-Agustench
    Affiliations
    Human Nutrition Unit, Hospital Universitari Sant Joan de Reus, IISPV, Rovira i Virgili University, Reus, Spain
    Search for articles by this author
  • P. López-Uriarte
    Affiliations
    Human Nutrition Unit, Hospital Universitari Sant Joan de Reus, IISPV, Rovira i Virgili University, Reus, Spain
    Search for articles by this author
  • M. Bulló
    Affiliations
    Human Nutrition Unit, Hospital Universitari Sant Joan de Reus, IISPV, Rovira i Virgili University, Reus, Spain
    Search for articles by this author
  • E. Ros
    Affiliations
    Lipid Clinic, Endocrinology and Nutrition Service, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain

    CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Spain
    Search for articles by this author
  • J.J. Cabré-Vila
    Affiliations
    Àrea Bàsica de Salut Reus-1, Institut Català de la Salut, Reus, Spain
    Search for articles by this author
  • J. Salas-Salvadó
    Correspondence
    Corresponding author at: Human Nutrition Unit, Department of Biochemistry and Biotechnology, Faculty of Medicine and Health Sciences, Rovira i Virgili University, Sant Llorenç 21, 43201 Reus, Spain. Tel.: +34 977 759312; fax: +34 977 759322.
    Affiliations
    Human Nutrition Unit, Hospital Universitari Sant Joan de Reus, IISPV, Rovira i Virgili University, Reus, Spain

    CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Spain
    Search for articles by this author
Published:December 23, 2009DOI:https://doi.org/10.1016/j.numecd.2009.08.005

      Abstract

      Background and aims

      Knowledge of the effect of nut consumption on metabolic syndrome (MetS) components is limited. We assessed the effects of nut intake on adiposity, serum lipids, insulin resistance, and inflammatory biomarkers in patients with MetS.

      Methods and results

      In a randomized, parallel-group, 12-week feeding trial, 50 patients with MetS were given recommendations for a healthy diet with or without supplementation with 30 g/day of raw nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) (Nut and Control diet groups, respectively). Adiposity measures, serum lipids, insulin, Homeostasis Model Assessment (HOMA), interleukin-6 (IL-6) and other inflammatory biomarkers, and 48-h fecal fat were determined basally and at study's completion. Moderate weight loss, decreased adiposity, and lower blood pressure occurred similarly after both diets. The Control, but not the Nut diet, was associated with significant (P<0.05) reduction of LDL-cholesterol, with mean changes of −0.36 versus −0.13 mmol/L, respectively (between-group differences, P=0.154). The Nut diet reduced fasting insulin by 2.60 μU/mL (95% CI, −4.62 to −0.59) and HOMA-insulin resistance by 0.72 (−1.28 to −0.16) (P<0.05 versus Control diet; both). Among inflammatory markers, the Nut diet resulted in changes of median plasma IL-6 of −1.1 ng/L (−2.7 to −0.1; P=0.035 versus Control diet), but adjustment for weight loss attenuated the significance of the association. Stool fat decreased with the Control diet and slightly increased with the Nut diet (P<0.05 for between-group differences).

      Conclusion

      Patients with MetS show decreased lipid responsiveness but improved insulin sensitivity after daily intake of 30 g of mixed nuts.

      Keywords

      Abbreviations:

      MetS (metabolic syndrome), HOMA (Homeostasis Model Assessment), CVD (cardiovascular disease), ATP III (Adult Treatment Panel III), REE (resting energy expenditure), O2 (oxygen), CO2 (carbon dioxide), SFA (saturated fatty acid), CRP (C-reactive protein), IL-6 (interleukin-6), MCP-1 (monocyte chemotactic protein-1), PAI-1 (plasminogen activator inhibitor-1), IL-18 (interleukin-18), ANCOVA (analysis of covariance), MUFA (monounsaturated fatty acid), PUFA (polyunsaturated fatty acid)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Nutrition, Metabolism and Cardiovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
        Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III).
        J Am Med Assoc. 2001; 285: 2486-2497
        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • Donato K.A.
        • Eckel R.H.
        • Franklin B.A.
        • et al.
        Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement.
        Circulation. 2005; 112: 2735-2752
        • Gami A.S.
        • Witt B.J.
        • Howard D.E.
        • Erwin P.J.
        • Gami L.A.
        • Somers V.K.
        • et al.
        Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.
        J Am Coll Cardiol. 2007; 49: 403-414
        • Grundy S.M.
        Metabolic syndrome pandemic.
        Arterioscler Thromb Vasc Biol. 2008; 28: 629-636
        • Phillips C.
        • Lopez-Miranda J.
        • Perez-Jimenez F.
        • McManus R.
        • Roche H.M.
        Genetic and nutrient determinants of the metabolic syndrome.
        Curr Opin Cardiol. 2006; 21: 185-193
        • Kelly Jr., J.H.
        • Sabaté J.
        Nuts and coronary heart disease: an epidemiological perspective.
        Br J Nutr. 2006; 96: S61-67
        • Mukuddem-Petersen J.
        • Oosthuizen W.
        • Jerling J.C.
        A systematic review of the effects of nuts on blood lipid profiles in humans.
        J Nutr. 2005; 135: 2082-2089
        • Jiang R.
        • Manson J.E.
        • Stampfer M.J.
        • Liu S.
        • Willett W.C.
        • Hu F.B.
        Nut and peanut butter consumption and risk of type 2 diabetes in women.
        J Am Med Assoc. 2002; 288: 2554-2560
        • Rajaram S.
        • Sabaté J.
        Nuts, body weight and insulin resistance.
        Br J Nutr. 2006; 96: S79-S86
        • Salas-Salvado J.
        • Casas-Agustench P.
        • Murphy M.M.
        • Lopez-Uriarte P.
        • Bullo M.
        The effect of nuts on inflammation.
        Asia Pac J Clin Nutr. 2008; 17: 333-336
        • Elosua R.
        • Marrugat J.
        • Molina L.
        • Pons S.
        • Pujol E.
        Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. The MARATHOM investigators.
        Am J Epidemiol. 1994; 139: 1197-1209
        • Weir J.B.
        New methods for calculating metabolic rate with special reference to protein metabolism.
        J Physiol. 1949; 109: 1-9
        • Assmann G.
        • Schriewer H.
        • Schmitz G.
        • Hägele E.O.
        Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2.
        Clin Chem. 1983; 29: 2026-2030
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and beta-cell function from plasma fasting glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Henry R.J.
        Clinical chemistry: principles and techniques.
        Harper and Row, New York1964 (p. 881)
        • Mukuddem- Petersen J.
        • Stonehouse Oosthuizen W.
        • Jerling J.C.
        • Hanekom S.M.
        • White Z.
        Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial.
        Br J Nutr. 2007; 97: 1144-1153
        • Lovejoy J.C.
        • Most M.M.
        • Lefevre M.
        • Greenway F.L.
        • Rood J.C.
        Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes.
        Am J Clin Nutr. 2002; 76: 1000-1006
        • Tapsell L.C.
        • Gillen L.J.
        • Patch C.S.
        • Batterham M.
        • Owen A.
        • Baré M.
        • et al.
        Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes.
        Diabetes Care. 2004; 27: 2777-2783
        • Estruch R.
        • Martínez-González M.A.
        • Corella D.
        • Salas-Salvadó J.
        • Ruiz-Gutiérrez V.
        • Covas M.I.
        • et al.
        Effects of a Mediterranean-style diet on cardiovascular risk factors. A randomized trial.
        Ann Intern Med. 2006; 145: 1-11
        • Lefevre M.
        • Champagne C.M.
        • Tulley R.T.
        • Rood J.C.
        • Most M.M.
        Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol.
        Am J Clin Nutr. 2005; 82: 957-963
        • Knopp R.H.
        • Retzlaff B.
        • Fish B.
        • Walden C.
        • Wallick S.
        • Anderson M.
        • et al.
        Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding.
        Arterioscler Thromb Vasc Biol. 2003; 23: 1437-1443
        • Hannah J.S.
        • Jablonshki K.A.
        • Howard B.V.
        The relationship between weight and response to cholesterol lowering diets in women.
        Int J Obes Relat Metab Disord. 1997; 21: 445-450
        • Jansen A.
        • Lopez-Miranda J.
        • Salas J.
        • Castro P.
        • Paniagua J.A.
        • Lopez-Segura F.
        • et al.
        Plasma lipid response to hypolipidemic diets in young health non-obese men varies with body mass index.
        J Nutr. 1998; 128: 1144-1149
        • Denke M.A.
        • Adams-Huet B.
        • Nguyen A.T.
        Individual cholesterol variation in response to a margarine- or butter-based diet. A study in families.
        J Am Med Assoc. 2000; 284: 2740-2747
        • Simonen P.
        • Gylling H.
        • Howard A.N.
        • Miettinen T.A.
        Introducing a new component of the metabolic syndrome: low cholesterol absorption.
        Am J Clin Nutr. 2000; 72: 82-88
        • Pihlajamäki J.
        • Gylling H.
        • Miettinen T.A.
        • Laakso M.
        Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.
        J Lipid Res. 2004; 45: 507-512
        • Segura R.
        • Javierre C.
        • Lizarraga M.A.
        • Ros E.
        Other relevant components of nuts: phytosterols, folate and minerals.
        Br J Nutr. 2006; 96 ([Erratum in: Br J Nutr 2008;99:447–448): S36-44
        • Fraser G.E.
        • Bennett H.W.
        • Jaceldo K.B.
        • Sabaté J.
        Effect on body weight of a free 76 kilojoule (320 calorie) daily supplement of almonds for six months.
        J Am Coll Nutr. 2002; 21: 275-283
        • Hollis J.
        • Mattes R.
        Effect of chronic consumption of almonds on body weight in healthy humans.
        Br J Nutr. 2007; 98: 651-656
        • Alper C.M.
        • Mattes R.D.
        Effects of chronic peanut consumption on energy balance and hedonics.
        Int J Obes Relat Metab Disord. 2002; 26: 1129-1137
        • Coelho S.B.
        • de Sales R.L.
        • Iyer S.S.
        • Bressan J.
        • Costa N.M.
        • Lokko P.
        • et al.
        Effects of peanut oil load on energy expenditure, body composition, lipid profile, and appetite in lean and overweight adults.
        Nutrition. 2006; 22: 585-592
        • Casas-Agustench P.
        • López-Uriarte P.
        • Bulló M.
        • Ros E.
        • Gómez-Flores A.
        • Salas-Salvadó J.
        Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety.
        Clin Nutr. 2009; 28: 39-45
        • García-Lorda P.
        • Megias Rangil I.
        • Salas-Salvadó J.
        Nut consumption, body weight and insulin resistance.
        Eur J Clin Nutr. 2003; 57: S8-11
        • Djoussé L.
        • Rudich T.
        • Gaziano J.M.
        Nut consumption and risk of hypertension in US male physicians.
        Clin Nutr. 2009; 28: 10-14
        • Riccardi G.
        • Giacco R.
        • Rivellese A.A.
        Dietary fat, insulin sensitivity and the metabolic syndrome.
        Clin Nutr. 2004; 23: 447-456
        • Lopez-Ridaura R.
        • Willett W.C.
        • Rimm E.B.
        • Liu S.
        • Stampfer M.J.
        • Manson J.E.
        • et al.
        Magnesium intake and risk of type 2 diabetes in men and women.
        Diabetes Care. 2004; 27: 134-140
        • Ros E.
        Nuts and novel biomarkers of cardiovascular disease.
        Am J Clin Nutr. 2009; 89: 1649S-1656S